Salivary Oxytocin as a Biomarker of Psychedelic Treatment
NCT07345858
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder (MDD)
Sponsor
University of Geneva, Switzerland